Database: Ovid MEDLINE(R) <1950 to February Week 4 2009>
Search Strategy:
1(losartan or cozaar).mp. [mp=title original title abstract name of substance word subject heading word] (6035)
2(telmisartan or micardis).mp. [mp=title original title abstract name of substance word subject heading word] (692)
3(candesartan or atacand).mp. [mp=title original title abstract name of substance word subject heading word] (1909)
4(eprosartan or teveten).mp. [mp=title, original title, abstract, name of substance word, subject heading word] (290)
5(irbesartan or avapro).mp. [mp=title, original title, abstract, name of substance word, subject heading word] (984)
6(olmesartan or benicar).mp. [mp=title, original title, abstract, name of substance word, subject heading word] (422)
7(valsartan or diovan).mp. [mp=title, original title, abstract, name of substance word, subject heading word] (1387)
81 or 2 or 3 or 4 or 5 or 6 or 7 (10325)
9(benazepril or lotensin).mp. [mp=title, original title, abstract, name of substance word, subject heading word] (496)
10(captopril or capoten).mp. [mp=title, original title, abstract, name of substance word, subject heading word] (11712)
11(cilazapril or inhibace).mp. [mp=title, original title, abstract, name of substance word, subject heading word] (614)
12(enalapril or vasotec).mp. [mp=title, original title, abstract, name of substance word, subject heading word] (6463)
13(fosinopril or monopril).mp. [mp=title, original title, abstract, name of substance word, subject heading word] (479)
14(lisinopril or prinivil or zestril).mp. [mp=title, original title, abstract, name of substance word, subject heading word] (2055)
15(moexipril or univasc).mp. [mp=title, original title, abstract, name of substance word, subject heading word] (80)
16(quinapril or accupril).mp. [mp=title, original title, abstract, name of substance word, subject heading word] (739)
17(ramipril or altace).mp. [mp=title, original title, abstract, name of substance word, subject heading word] (1820)
18(perindopril or aceon or coversyl).mp. [mp=title, original title, abstract, name of substance word, subject heading word] (1449)
19(trandolapril or mavik).mp. [mp=title, original title, abstract, name of substance word, subject heading word] (586)
2011 or 9 or 17 or 12 or 15 or 14 or 18 or 19 or 10 or 13 or 16 (23267)
218 and 20 (2077)
22limit 21 to (english language and humans) (964)
23limit 22 to (clinical trial, all or clinical trial or comparative study or controlled clinical trial or evaluation studies or meta analysis or multicenter study or randomized controlled trial or “review”) (729) (18637) (739805) (366520)
24observational stud$.mp.
25exp Cohort Studies/or cohort.mp.
26exp Retrospective Studies/or retrospective$.mp.
27systematic review.mp. (13769)
2827 or 25 or 24 or 26 (1037318)
2922 and 28 (152)
3023 or 29 (751)
31from 30 keep 1–712 (712)
32from 31 keep 1–712 (712)

From: Appendix B, Search strategies

Cover of Drug Class Review: Direct Renin Inhibitors, Angiotensin Converting Enzyme Inhibitors, and Angiotensin II Receptor Blockers
Drug Class Review: Direct Renin Inhibitors, Angiotensin Converting Enzyme Inhibitors, and Angiotensin II Receptor Blockers: Final Report [Internet].
Norris S, Weinstein J, Peterson K, et al.
Portland (OR): Oregon Health & Science University; 2010 Jan.
Copyright © 2009, Oregon Health & Science University, Portland, Oregon.

NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.